Trinity Biotech USA

FDA Regulatory Profile

Trinity Biotech USA appears in FDA public data with 1 recall, 11 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-2292-2025, Class II) was initiated on July 22, 2025. Its most recent 510(k) clearance was granted on May 22, 2014.

Summary

Total Recalls
1
510(k) Clearances
11
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-2292-2025Class IIBartels ELISA Legionella Urinary Antigen. Model Number: B1029-440. In Vitro Diagnostic test kit fJuly 22, 2025

Recent 510(k) Clearances

K-NumberDeviceDate
K140455CAPTIA MEASLES IGMMay 22, 2014
K033106CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KITJuly 13, 2004
K033105CAPTIA HSV 1 IGG TYPE SPECIFIC ELISA KITJuly 13, 2004
K033083BORRELIA BURGDORFERI IGG/IGM ELISA TEST SYSTEMNovember 26, 2003
K033067PYLORI IGGNovember 26, 2003
K033070BORRELIA BURGDORFERI IGM ELISA TEST SYSTEMNovember 26, 2003
K033079CHLAMYDIA IGG ELISA TEST SYSTEMNovember 26, 2003
K033051LEGIONELLA PNEUMOPHILA IGG/IGMNovember 26, 2003
K033064MYCOPLASMA IGGNovember 26, 2003
K993839ENA PROFILE ELISA TEST SYSTEMJanuary 12, 2000
K992665MACRA LP(A) ENZYME IMMUNOASSAY KITNovember 26, 1999